ERBB2 and breast cancer: However, the aberrant signalling pathways by which they contribute to breast carcinogenesis and breast cancer type can be classified into various subtypes based on the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) patterns, which implied significant overall and disease-free survival advantages [4–6].